SUNY

Brenmiller Energy Reports 2022 Year-End Financial Results and Operational Update

Retrieved on: 
星期三, 三月 22, 2023
Environmental Health, Other Energy, Nuclear, Utilities, Green Technology, Oil, Gas, Coal, Alternative Energy, Environment, Energy, Sustainability, Romania, Viridi, State University of New York at Purchase, BofA Securities, Ernst & Young Entrepreneur of the Year Award, Electricity, TES, New York Power Authority, Philip Morris, GHG, Research, Consultant, Sale, Government, Green, Kilowatt-hour, Pioneer, Investment, SUNY, NYPA, Engineering, Natural gas, Enel, European Investment Bank, Biomass, Cryptocurrency, Renewable energy, New Technologies Demonstrator Programme, European

Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy”) (Nasdaq: BNRG;TASE: BNRG), a global leader in thermal energy storage (“TES”), today announced financial results for the twelve months ended December 31, 2022, in addition to operational updates.

Key Points: 
  • Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy”) (Nasdaq: BNRG;TASE: BNRG), a global leader in thermal energy storage (“TES”), today announced financial results for the twelve months ended December 31, 2022, in addition to operational updates.
  • In 2022, we have proven ourselves as a global leader in providing net-zero heat solutions for industrial and utility markets.
  • With a robust pipeline and accelerating commercial momentum, we are optimistic about the year ahead,” stated Avi Brenmiller, Chairman and Chief Executive Officer of Brenmiller Energy.
  • For Enel, one of the largest energy companies in the world, we built and inaugurated the first-of-its-kind TES system at an active power plant.

Synchron to Begin Patient Enrollment for the COMMAND Trial of Brain-Computer Interface at Gates Vascular Institute

Retrieved on: 
星期一, 三月 20, 2023
Hardware, FDA, Health Technology, Technology, Nanotechnology, Surgery, Medical Devices, Neurology, Clinical Trials, Biotechnology, Science, Software, Other Science, Research, Health, Mobile, Wireless, Extremities, UB, Kaleida Health, University, Gates Vascular Institute, BCI, Jacobs School of Medicine and Biomedical Sciences, COMMAND, Buffalo buffalo Buffalo buffalo buffalo buffalo Buffalo buffalo, MBA, Brain, Biomedical sciences, CMO, Doctor of Philosophy, Computer, Jacobs Institute for Design Innovation, Trial of the century, Paralysis, Blood, Motor cortex, University of Pittsburgh Medical Center, Professor, MD, FAHA, Patient, Physician, SUNY, FACS, SUNY UB, EFS, IDE, Mount Sinai Health System, JAMA Neurology, Safety, Medical imaging, Medical device, Management, Medicine, Beckman Coulter, Neurosurgery

The COMMAND trial is being conducted under the first investigational device exemption (IDE) awarded by the FDA to a company assessing a permanently implanted BCI.

Key Points: 
  • The COMMAND trial is being conducted under the first investigational device exemption (IDE) awarded by the FDA to a company assessing a permanently implanted BCI.
  • The new site at Gates Vascular Institute marks the third approved COMMAND trial location, joining Mount Sinai Health System in New York and the University of Pittsburgh Medical Center.
  • The FDA granted Breakthrough Device designation to Synchron in August 2020 and an IDE in July 2021.
  • There is no guarantee of participation and principal investigators make the final determination of patient eligibility.

iECURE Appoints Gabriel M. Cohn, M.D., as Chief Medical Officer

Retrieved on: 
星期四, 三月 16, 2023
Science, Biotechnology, Research, Pharmaceutical, Health, Health Technology, Genetics, Other Health, Assistant, OvaScience, ACOG, Baystate Health, Gene editing, Phenylketonuria, Bangladesh Technical Education Board, University of Massachusetts Amherst, Isenberg School of Management, Health Canada, Tufts University School of Medicine, PKU, Patient, American College, Medical director, FACMG, MBA, Food and Drug Administration, DSM-IV codes, FDA, CMO, Obstetrics and gynaecology, SUNY, Growth, State University of New York Upstate Medical University, Medical genetics, Food, Therapy, IND, Drug, OTC, University, Liver, Pharmaceutical industry, Genomics, Gynaecology, Obstetrics

iECURE , a gene editing company focused on mutation-agnostic in vivo gene insertion, or knock-in, editing for the treatment of liver disorders with significant unmet need, today announced the appointment of Gabriel M. Cohn, M.D., MBA as Chief Medical Officer.

Key Points: 
  • iECURE , a gene editing company focused on mutation-agnostic in vivo gene insertion, or knock-in, editing for the treatment of liver disorders with significant unmet need, today announced the appointment of Gabriel M. Cohn, M.D., MBA as Chief Medical Officer.
  • “Gabe’s experience in clinical development as a CMO will be crucial as we begin the process of global regulatory submissions and patient dosing.
  • from SUNY Health Science Center at Syracuse and MBA from the Isenberg School of Management at the University of Massachusetts Amherst.
  • He completed a residency in Obstetrics & Gynecology at SUNY HSC at Syracuse and a fellowship in Medical Genetics at the National Institutes of Health.

CUNY’s Brooklyn College Selects YuJa Enterprise Video Platform to Serve More Than 15,000 Students Campuswide

Retrieved on: 
星期三, 三月 8, 2023
Apps, Applications, Mobile, Wireless, Technology, Software, Audio, Video, Networks, Internet, University, Data Management, Education, Yuzu, Online video platform, Learning, Teaching, State university system, Student, CUNY, City University, State University of New York, City, SUNY, Kaltura, LMS, Brooklyn College, Video game

Part of the City University of New York (CUNY), Brooklyn College has selected the YuJa Enterprise Video Platform to serve its more than 15,000 students who come from 136 countries around the world.

Key Points: 
  • Part of the City University of New York (CUNY), Brooklyn College has selected the YuJa Enterprise Video Platform to serve its more than 15,000 students who come from 136 countries around the world.
  • YuJa’s Video Platform is an all-in-one video experience that will enable the institution to enhance teaching and learning with capabilities like lecture capture, auto captioning, video quizzing, and through embedding videos directly into Blackboard Ultra, the institution’s learning management system.
  • The Video Platform also provides cloud-based, scalable storage, adaptive bitrate streaming, device compatibility, and more.
  • “YuJa works with a number of colleges in both the CUNY and State University of New York (SUNY) systems,” said Nathan Arora, Chief Business Officer at YuJa, Inc. “We’re excited for Brooklyn College instructors and students to experience the powerful tools available within the YuJa Video Platform that will integrate seamlessly into their LMS and allow the college to consolidate ed-tech tools.”

Bright Minds Biosciences Announces Non-Executive Director Appointment

Retrieved on: 
星期五, 二月 17, 2023
CMO, Elefsina, Biomedical sciences, Therapy, Michael J. Lenardo, SUNY, Rare, Proteostasis, NIH, Pain, Consultant, University, Neurology, Audit committee, Neuropharmacology, ATyr Pharma, Interim, CNS, Compensated emancipation, Weill Cornell Medicine, Jacobs School of Medicine and Biomedical Sciences, NOT, DSM-IV codes, FOR, School, Option, Epilepsy, The Michael J. Fox Foundation, Acadia Pharmaceuticals, CSE, Pimavanserin, MD, Pharmaceutical industry, Weill Cornell Medical Center, Buffalo

VANCOUVER, British Columbia, Feb. 17, 2023 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE:DRUG) (NASDAQ:DRUG) (“Bright Minds” or the “Company”), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced the appointment to its board of directors (the “Board”) of David Weiner, MD, as a non-executive director. The appointment is effective immediately.

Key Points: 
  • “I am delighted to welcome David to the Bright Minds Board.
  • David holds several patents in the area of selective serotonin modulators, and we look forward to his contributions to the Company,” said Ian McDonald, CEO and Co-founder of Bright Minds Biosciences.
  • “It is an honor to join the Bright Minds Board as the Company transitions from a discovery to a development organization.
  • I am eager to share my perspectives and experience to help Bright Minds progress its innovative clinical and preclinical drug discovery programs,” stated David Weiner, MD.

SUNY Upstate Medical University Selects YuJa Enterprise Video Platform to Provide Cloud-Based Media Management Campuswide

Retrieved on: 
星期六, 二月 11, 2023
University, Data Management, Education, Technology, Health, General Health, Training, Software, Hospitals, Audio, Video, Internet, Faculty, D2L, State University of New York Upstate Medical University, Student, Teaching, SUNY, Marketing, Nursing, Yuzu

SUNY Upstate Medical University in Syracuse, New York, has selected YuJa, Inc. to provide a cloud-based media management system to use for teaching, training, marketing and communications throughout the academic medical center.

Key Points: 
  • SUNY Upstate Medical University in Syracuse, New York, has selected YuJa, Inc. to provide a cloud-based media management system to use for teaching, training, marketing and communications throughout the academic medical center.
  • In addition to cloud-based media management, the institution was seeking a product to replace its former platform that features a user-friendly interface to manage and view media on any device.
  • The solution also needed to seamlessly integrate with D2L Brightspace, its learning management system, and other third-party vendors used for education and collaboration throughout the institution.
  • A number of SUNY’s institutions have already implemented one or more solutions from YuJa’s suite of ed-tech products.

Digital Publishing Global Market Report 2023: Increasing Digitization of Books and Educational Content Fuels 10% Annual Growth

Retrieved on: 
星期三, 二月 15, 2023
Benchmark, Open educational resources, Television, Generation Z, Coronavirus, Millennials, Create, TRAI, SUNY, Textbook, CUNY, Sale, Android, Generation, OTT, Telecom Regulatory Authority of India, Agriculture, Growth, COVID, Book, Digital, COVID 19, Tablet, Video game, Publishing, Generation X

DUBLIN, Feb. 15, 2023 /PRNewswire/ -- The "Digital Publishing Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 15, 2023 /PRNewswire/ -- The "Digital Publishing Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
  • The regions covered in the digital publishing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
  • The increasing digitization of books and educational information is contributing to the growth of the digital publishing market.
  • The threat from open educational resources and alternative textbook sources is one of the biggest challenges faced by the digital publishing market.

SUNY Fredonia Prioritizing Student Success with Akademos Partnership

Retrieved on: 
星期二, 二月 14, 2023
SUNY, State university system, Textbook, Academus, State University of New York at Fredonia, Equitable Access to Care and Health Act, Student, Education, Architecture, Faculty, Multimedia, UMBC University Commons, Student Choice Initiative, Social, FSA, Online shopping, Management, Tutoring

FREDONIA, N.Y., Feb. 14, 2023 /PRNewswire/ -- The State University of New York at Fredonia has partnered with Akademos to launch an online bookstore for the Summer 2023 semester. The on-campus bookstore will continue to operate in University Commons.

Key Points: 
  • FREDONIA, N.Y., Feb. 14, 2023 /PRNewswire/ -- The State University of New York at Fredonia has partnered with Akademos to launch an online bookstore for the Summer 2023 semester.
  • The platform also provides data and analytics to help oversee individual student engagement and support student success.
  • Fredonia is known for its strong academic programs, attractive architecture and grounds, rich campus life, and commitment to student engagement and success.
  • All aspects of course material purchasing and delivery are taken care of, so you can focus on what matters - student success.

ThayerMahan Protects Subsea Cables

Retrieved on: 
星期四, 二月 2, 2023
State University of New York, Artificial intelligence, Automatic, SUNY, Synthetic aperture sonar, New York State Energy Research and Development Authority, International Disability and Development Consortium, Connecticut College, Development, Wind, State university system, Algorithm, Maintenance, NYSERDA, Database, Research, Failure, Partnership, SAS, Transport, Television

GROTON, Conn., Feb. 2, 2023 /PRNewswire/ -- Connecticut-based ThayerMahan, Inc, a world leader in autonomous maritime solutions, demonstrated that its SeaScout system can detect damage to export and transmission cables that carry power from offshore wind turbines to the onshore power making it possible to identify cable damage prior to failure.

Key Points: 
  • ThayerMahan teamed with OceanIQ , part of the Global Marine Group to analyze a database of cable failures and determine primary cable failure modalities.
  • As part of the study, ThayerMahan acquired bona fide wind farm cables and simulated each of the failure modalities.
  • Gail Clark, Managing Director of OceanIQ said "ThayerMahan's demonstrated capability will be a game changer for subsea power cable maintenance.
  • "  Niko joined ThayerMahan as an intern in 2020, graduated from Connecticut College in 2021, signed on as a full-time ThayerMahan team member, and presented project findings at the National Offshore Wind R&D Symposium in 2022.

Normunity Appoints Olga Granaturova as Chief Operating Officer and Chief Business Officer

Retrieved on: 
星期四, 一月 19, 2023
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, R, Pharmacy, Merck, Therapy, Entrepreneurship, Parthenon, MD, London, Evotec, Woman, HEC Paris, SUNY, Growth, BS, Drug discovery, Cancer, New York University Stern School of Business, Pfizer, MBA, Multimedia, Paris, London School of Business and Finance, Pharmaceutical industry, Economics, Buffalo

Normunity, Inc ., a biotechnology company creating novel precision anti-cancer immunotherapies, today announced the appointment of Olga Granaturova, MBA, as Chief Operating Officer and Chief Business Officer.

Key Points: 
  • Normunity, Inc ., a biotechnology company creating novel precision anti-cancer immunotherapies, today announced the appointment of Olga Granaturova, MBA, as Chief Operating Officer and Chief Business Officer.
  • View the full release here: https://www.businesswire.com/news/home/20230119005216/en/
    Normunity COO-CBO Olga Granaturova (Photo: Business Wire)
    “We are delighted to welcome Olga to the Normunity Leadership Team.
  • Her hands-on experience in business creation, financing and business development will play a vital role as we continue to grow,” said Rachel Humphrey, MD, founding Chief Executive Officer of Normunity.
  • She joins Normunity after serving as co-founder and Chief Operating Officer of Parthenon Therapeutics, a biotech company creating a novel class of anti-cancer therapies.